Liposomal cytarabine in cerebrospinal fluidBOYD, Kevin; JENNER, Matthew; TRELEAVEN, Jennie et al.British journal of haematology. 2009, Vol 145, Num 6, issn 0007-1048, p. 679Article

Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitisKLEITER, I; HANS, V. H; SCHUIERER, G et al.Journal of neurology, neurosurgery and psychiatry. 2004, Vol 75, Num 9, pp 1346-1348, issn 0022-3050, 3 p.Article

Biochemical modulation of cytarabine triphosphate by clofarabineCOOPER, Todd; AYRES, Mary; NOWAK, Billie et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 4, pp 361-368, issn 0344-5704, 8 p.Article

Modeling the pharmacodynamics of highly schedule-dependent agents : Exemplified by cytarabine-based regimens in acute myeloid leukemiaBRAESS, Jan; FIEGL, Michael; LORENZ, Isolde et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7415-7425, issn 1078-0432, 11 p.Article

Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemiaINSIRIPONG, S; THAISAMAKR, S.Chot Mai Het Thang Phaet. 1996, Vol 79, Num 9, pp 568-571, issn 0125-2208Article

A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cellsYAMAUCHI, Takahiro; UEDA, Takanori.Biochemical pharmacology. 2005, Vol 69, Num 12, pp 1795-1803, issn 0006-2952, 9 p.Article

Clinical laboratory identification of liposomal cytarabine in cerebrospinal fluidMANGRAVITI, Diane; GENZEN, Jonathan R.American journal of hematology. 2010, Vol 85, Num 6, pp 459-460, issn 0361-8609, 2 p.Article

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicityHARTFORD, Christine M; SHIWEI DUAN; DELANEY, Shannon M et al.Blood. 2009, Vol 113, Num 10, pp 2145-2153, issn 0006-4971, 9 p.Article

Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemiaPENATE, Y; GUILLERMO, N; HERNANDEZ-MACHIN, B et al.British journal of dermatology (1951). 2009, Vol 160, Num 5, pp 1122-1123, issn 0007-0963, 2 p.Article

Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside : The Taiwan experienceCHEN, Y.-C; LIN, S.-F; YAO, M et al.Seminars in hematology. 1996, Vol 33, Num 4, pp 30-34, issn 0037-1963, SUP3Conference Paper

Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosisCOLAGRANDE, Marianna; DI IANNI, Mauro; CIURNELLI, Raffaella et al.British journal of haematology. 2007, Vol 138, Num 6, pp 812-813, issn 0007-1048, 2 p.Article

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignanciesGOTOH, M; YOSHIZAWA, S; OHYASHIKI, K et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 7, pp 955-960, issn 0268-3369, 6 p.Article

Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemiaBINGNAN ZHANG; BOLOGNIA, Jean; MARKS, Peter et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 303-307, issn 0344-5704, 5 p.Article

Pharmacokinetics and Toxicity of Intrathecal Liposomal Cytarabine in Children and Adolescents Following Age-Adapted DosingPEYRL, Andreas; SAUERMANN, Robert; CHOCHOLOUS, Monika et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 165-173, issn 0312-5963, 9 p.Article

Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502ATTAR, Eyal C; JOHNSON, Jeffrey L; BLUM, William et al.Journal of clinical oncology. 2013, Vol 31, Num 7, pp 923-929, issn 0732-183X, 7 p.Article

Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patientsKYUNG IM KIM; HUH, Ik-Soo; KIM, In-Wha et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 403-410, issn 0959-8049, 8 p.Article

Cytarabine, Ki-67, and SOX11 in Patients With Mantle Cell Lymphoma Receiving Rituximab-Containing Autologous Stem Cell Transplantation During First RemissionCHAKHACHIRO, Zaher I; SALIBA, Rima M; SAMUELS, Barry I et al.Cancer. 2013, Vol 119, Num 18, pp 3318-3325, issn 0008-543X, 8 p.Article

High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 TrialSCHAICH, Markus; PARMENTIER, Stefani; EINSELE, Hermann et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2094-2102, issn 0732-183X, 9 p.Article

Sense and nonsense of high-dose cytarabine for acute myeloid leukemiaLÖWENBERG, Bob.Blood. 2013, Vol 121, Num 1, pp 26-28, issn 0006-4971, 3 p.Article

Treatment of Adults With Acute Lymphoblastic Leukemia: Do the Specifics of the Regimen Matter?: Results From a Prospective Randomized TrialLAMANNA, Nicole; HEFFNER, Leonard T; WEISS, Mark A et al.Cancer. 2013, Vol 119, Num 6, pp 1186-1194, issn 0008-543X, 9 p.Article

décitabine ^(DACOGEN°): Leucémies aiguës myéloblastiques: pas de progrèsLa Revue Prescrire. 2013, Vol 33, Num 362, pp 894-896, issn 0247-7750, 3 p.Article

Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemiaBAIJUN FANG; YUZHANG LIU; JIAN ZHOU et al.American journal of hematology. 2012, Vol 87, Num 1, pp 126-127, issn 0361-8609, 2 p.Article

A Scoring System to Predict the Risk of Death During Induction With Anthracycline Plus Cytarabine-Based Chemotherapy in Patients With De Novo Acute Myeloid LeukemiaVALCARCEL, David; MONTESINOS, Pau; LLORENTE, Andrés et al.Cancer. 2012, Vol 118, Num 2, pp 410-417, issn 0008-543X, 8 p.Article

Clinical and Proteomic Characterization of Acute Myeloid Leukemia With Mutated RASKADIA, Tapan M; KANTARJIAN, Hagop; RAVANDI, Farhad et al.Cancer. 2012, Vol 118, Num 22, pp 5550-5559, issn 0008-543X, 10 p.Article

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabinePABST, Thomas; VELLENGA, Edo; LEGDEUR, Marie-Cecile et al.Blood. 2012, Vol 119, Num 23, pp 5367-5373, issn 0006-4971, 7 p.Article